| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/02/2007 | WO2007087154A2 Methods for enhancing therapeutic effects of a neurotoxin |
| 08/02/2007 | WO2007087151A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 08/02/2007 | WO2007086545A1 Method for screening cell function regulator |
| 08/02/2007 | WO2007086493A1 Medicine for transnasal administration |
| 08/02/2007 | WO2007086490A1 Remedy for disease associated with choroidal angiogenesis |
| 08/02/2007 | WO2007086446A1 Pharmaceutical composition for prevention or treatment of cardiac failure |
| 08/02/2007 | WO2007086395A1 Photodynamic therapy kit |
| 08/02/2007 | WO2007086327A1 Dermal papilla cell growth promoter |
| 08/02/2007 | WO2007068070A3 Composition containing an inhibitor of phosphodiesterase iii and a therapeutic alcohol for the treatment of atherosclerosis diseases |
| 08/02/2007 | WO2007055743A3 Treatment of obesity and related disorders |
| 08/02/2007 | WO2007005144A3 Improved allergen-specific immunotherapy |
| 08/02/2007 | WO2006135713A3 Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators and a farnesyl transferase inhibitor |
| 08/02/2007 | WO2006133391A3 Improved treatment for anemia using a hif-alpha stabilising agent |
| 08/02/2007 | WO2006113602A3 Ascorbate binding peptides |
| 08/02/2007 | WO2005011595A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
| 08/02/2007 | WO2004091519A3 Methods of preventing or treating respiratory conditions |
| 08/02/2007 | WO2004067724A3 Methods of identifying and designing cell surface receptor inhibitors |
| 08/02/2007 | US20070179601 Methods and apparatus for stenting comprising enhanced embolic protections coupled with improved protections against restenosis and trombus formation |
| 08/02/2007 | US20070179597 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
| 08/02/2007 | US20070179596 Medical Devices, Drug Coatings And Methods for Maintaining the Drug Coatings Thereon |
| 08/02/2007 | US20070179595 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
| 08/02/2007 | US20070179594 Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon |
| 08/02/2007 | US20070179593 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protecions against restenosis and thrombus formation |
| 08/02/2007 | US20070179195 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
| 08/02/2007 | US20070179099 Methods of cholesterol reduction using isoflavones |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178467 Gm1 promoter and use thereof |
| 08/02/2007 | US20070178132 Injectable chondrocyte implant |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178083 Medicinal compositions containing Fc receptor gamma-chain activator |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis) |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | CA2637917A1 Therapeutic agents for diseases involving choroidal neovascularization |
| 08/02/2007 | CA2637463A1 Synergistic compositions for treating hiv |
| 08/02/2007 | CA2635920A1 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 08/01/2007 | EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 08/01/2007 | EP1813611A1 1-substituted-3- beta-d-glucopyranosylated nitrogenous hetero- cyclic compounds and medicines containing the same |
| 08/01/2007 | EP1813606A1 Amide compound |
| 08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 08/01/2007 | EP1813285A1 Preventive or therapeutic agent for neuropathic pain |
| 08/01/2007 | EP1813284A1 Pharmaceutical composition |
| 08/01/2007 | EP1813283A1 Remedy for neuropathic pain |
| 08/01/2007 | EP1813282A1 Remedy for angiospasm accompanying subarachnoid hemorrhage contianing thrombin receptor antagonist as the active ingredient |
| 08/01/2007 | EP1813277A1 Dispenser for dispensing two or more substances |
| 08/01/2007 | EP1813273A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 08/01/2007 | EP1812070A1 Treatment of restless legs syndrome |
| 08/01/2007 | EP1812069A2 Method for treating hiv infection through co-administration of tipranavir and etravirine |
| 08/01/2007 | EP1812049A2 Kallikrein inhibitors and uses thereof |
| 08/01/2007 | EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 08/01/2007 | EP1811996A1 Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
| 08/01/2007 | EP1294401B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 08/01/2007 | EP1287134B1 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1248609A4 Method of treating benign forgetfulness |
| 08/01/2007 | EP1007537B1 Receptor protein designated 2f1 |
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 08/01/2007 | CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities |
| 08/01/2007 | CN101010079A Remedy for glomerular diseae |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007172A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 08/01/2007 | CN101007171A Skeleton slow releasing implant for deworming from dogs and its preparation method |
| 08/01/2007 | CN101007170A Preparation method of sustained release formulation for treating echinococcosis |
| 08/01/2007 | CN101007027A Application method of neural regulation protein in the treatment of cardiovascular diseases and its composition |
| 08/01/2007 | CN101006982A Anticancer medicine composition of taxane and its synergist |
| 08/01/2007 | CN101006980A Anticancer composition containing taxane and alkaloids |
| 08/01/2007 | CN101006979A Anticancer composition containing taxane and topoenzyme inhibitor |
| 08/01/2007 | CN101006978A Anticancer medicinal composition containing taxane and alkylating agents |
| 08/01/2007 | CN101006977A Anticancer medicinal composition containing taxane and hormones drug |
| 08/01/2007 | CN101006976A Anticancer medicinal composition of loaded taxane and its synergist |
| 07/31/2007 | US7251525 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250399 Compounds having growth hormone releasing activity |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250262 For the diagnosis and treatment of patients with disorders including anemias |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound |